STANDARD BIOTOOLS INC (LAB)
US34385P1084 - Common Stock
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | N/A | N/A | 47.80M | |||
| Cash Equivalents | 210.65M | 51.70M | 81.30M | 28.50M | 20.70M | |||
| Marketable Securities | 155.68M | 63.19M | 84.50M | N/A | 0.00 | |||
| Receivables | 35.32M | 19.66M | 17.30M | 18.30M | 25.40M | |||
| Inventories | 42.64M | 20.53M | 21.50M | 20.80M | 19.70M | |||
| Other Current Assets | 9.32M | 3.13M | 4.30M | 4.50M | 4.00M | |||
| Total Current Assets | 453.61M | 158.22M | 208.80M | 72.10M | 117.70M | |||
| Non-Current Assets | ||||||||
| PPE Net | 72.25M | 54.85M | 59.50M | 65.20M | 55.60M | |||
| Investments And Advances | N/A | N/A | N/A | N/A | N/A | |||
| Goodwill | 106.34M | 106.32M | 106.30M | 106.40M | 106.60M | |||
| Intangibles | 23.37M | 1.41M | 13.20M | 29.20M | 42.20M | |||
| Other Non-Current Assets | 22.59M | 2.28M | 2.50M | 2.40M | 2.70M | |||
| Total Non-Current Assets | 227.93M | 164.85M | 181.50M | 203.10M | 207.10M | |||
| TOTAL ASSETS | 681.54M | 323.07M | 390.30M | 275.20M | 324.80M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 54.91M | 59.53M | 2.10M | 6.80M | N/A | |||
| Accrued Expenses | 37.81M | 24.89M | 19.00M | 16.60M | 31.60M | |||
| Accounts Payable | 10.93M | 9.24M | 7.90M | 10.60M | 9.20M | |||
| Other Current Liabilities | 16.97M | 15.67M | 14.40M | 15.50M | 13.50M | |||
| Total Current Liabilities | 120.61M | 109.33M | 43.40M | 49.60M | 54.20M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 299.00K | 3.98M | 62.80M | 64.20M | 54.20M | |||
| Deferred Taxes/Income | 841.00K | 841.00K | 1.10M | 4.30M | 8.70M | |||
| Other Non-Current Liabilities | 70.45M | 45.71M | 53.20M | 62.50M | 68.50M | |||
| Total Non-Current Liabilities | 71.59M | 50.54M | 117.10M | 131.00M | 131.50M | |||
| TOTAL LIABILITIES | 192.21M | 159.87M | 160.50M | 180.60M | 185.70M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -1.15B | -1.00B | -926.10M | -736.00M | -676.80M | |||
| Additional Paid In Capital | 1.69B | 860.82M | 847.00M | 831.40M | 815.60M | |||
| Common Shares | 390.00K | 311.34M | 311.40M | 100.00K | 100.00K | |||
| Treasury Stock | -46.47M | -5.98M | -600.00K | N/A | N/A | |||
| Other Shareholders' Equity | -1.41M | -2.22M | -1.40M | -900.00K | 100.00K | |||
| Shares Outstanding | 372.26M | 80.23M | 79.50M | 76.90M | 74.50M | |||
| Tangible Book Value per Share | 0.97 | -3.19 | -2.53 | -0.53 | -0.13 | |||
| Total Shareholders' Equity | 489.33M | 163.20M | 229.80M | 94.60M | 139.10M | |||
| TOTAL LIABILITIES AND EQUITY | 681.54M | 323.07M | 390.30M | 275.20M | 324.80M | |||
| Statistics | ||||||||
| Debt/Equity | 0.00 | 0.02 | 0.27 | 0.68 | 0.39 | |||
| Current Ratio | 3.76 | 1.45 | 4.81 | 1.45 | 2.17 | |||
| Return On Assets (ROA) | -25.03% | -23.11% | -48.71% | -21.51% | -16.32% | |||
| Return On Equity (ROE) | -34.86% | -45.74% | -82.72% | -62.58% | -38.10% | |||
All data in USD , ROIC based on taxRate of 0.21